Edithistory:Etripamil
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1321775820 | 2025-11-12T16:17:59Z | Significa liberdade | Declining submission: npov - Submission is not written in a formal, neutral encyclopedic tone |
| 1321766108 | 2025-11-12T14:59:35Z | ~2025-33064-44 | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1321766069 | 2025-11-12T14:59:12Z | ~2025-33064-44 | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1321765509 | 2025-11-12T14:54:35Z | Significa liberdade | [[WP:AFC|AFC]] draft |
| 1321765500 | 2025-11-12T14:54:34Z | Significa liberdade | Significa liberdade moved page [[Etripamil]] to [[Draft:Etripamil]] without leaving a redirect: [[WP:DRAFTIFY|Not ready]] for mainspace, incubate in draftspace. Reason/s: promotional/ad |
| 1321645653 | 2025-11-11T20:07:24Z | Innerstream | |
| 1321645237 | 2025-11-11T20:04:44Z | Innerstream | |
| 1317099241 | 2025-10-16T09:22:25Z | Fram | Not used on enwiki |
| 1317090123 | 2025-10-16T07:29:45Z | Mahmoudalrawi | |
| 1317089912 | 2025-10-16T07:27:32Z | Mahmoudalrawi | /* Administration and Safety */ |
| 1317089719 | 2025-10-16T07:25:37Z | Mahmoudalrawi | [[WP:AES|←]]Created page with ''''Etripamil''' (brand name ''Cardamyst''®) is a novel, fast-acting non-dihydropyridine L-type [[calcium channel blocker]], designed as [[intranasal]] ([[nasal spray]]) for the on-demand treatment of [[paroxysmal supraventricular tachycardia]] (PSVT). It represents a major shift in managing this condition, moving therapy from the hospital to the patient's home. Developed by Milestone Pharmaceuticals, it is the first of its kind, offering a practical and...' |
